Allegro Diagnostics Raises $5.4M to Advance Lung Cancer Test

Proceeds from the financing will support the commercialization of Allegro's lead genomic test, BronchoGen, in 2012.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.